Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy

Folia Neuropathologica

Volumn 48, Issue 2, 2010, Pages 81-92

  Bobek Billewicz, Barbara ^a   Stasik Pres, Gabriela ^a   Majchrzak, Henryk ^b   Zarudzki, Łukasz ^a  

^a Institute of Oncology   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diffusion weighted imaging; MR spectroscopy; Perfusion weighted imaging; Radiation injury; Recurrence

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; RADIATION INJURY; RADIATION NECROSIS; WHITE MATTER; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RETROSPECTIVE STUDY; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77954725478     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ando K, Ishikura R, Nagami Y, Morikawa T, Takada Y, Ikeda J, Nakao N, Matsumoto T, Arita N. Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions. Nippon Igaku Hoshasen Gakkai Zasshi 2004; 64: 121-126.
2. Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, Kochi M, Morishita S, Yamashita Y. Diffusion-Weighted Imaging of Radiation-Induced Brain Injury for Differentiation from Tumor Recurrence. AJNR Am J Neuroradiol 2005; 26: 1455-1460. (Pubitemid 43733446)
3. Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S. Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging. AJNR Am J Neuroradiol 2009; 30: 367-372.
4. Brandes AA, Tosoni A, Spagnolli F, Frezza G, Leonardi M, Calbucci F, Franceschi E. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology. Neuro Oncol 2008; 10: 361-367.
5. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms and management of pseudo-progression in malignant gliomas. Lancet Oncol 2008; 9: 453-461. (Pubitemid 351597795)
6. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007; 48: 1468-1481. (Pubitemid 47397397)
7. Chenevert T, McKeever P, Ross B. Monitoring early response of experimental brain tumors to therapy using diffusion magneticresonance imaging. Clin Cancer Res 1997; 3: 1457-1466. (Pubitemid 27431551)
8. Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer 2005; 104: 2168-2173.
9. Czernicki T, Szeszkowski W, Marchel A, Gołebiowski M. Spectral changes in postoperative MRS in high-grade gliomas and their effect on patient prognosis. Folia Neuropathol 2009; 47: 43-49.
10. Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR. Low-Grade Gliomas: Do Changes in rCBV Measurements at Longitudinal Perfusionweighted MR Imaging Predict Malignant Transformation? Radiology 2008; 247: 170-178.
11. Di Chiro G, Oldfield E, Wright DC, De Michele D, Katz DA, Patronas NJ, Doppman JL, Larson SM, Ito M, Kufta CV. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol 1988; 150: 189-197. (Pubitemid 18027033)
12. Forsyth PA, Kelly PJ, Cascino TL, Scheithauer BW, Shaw EG, Dinapoli RP, Atkinson EJ. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg 1995; 82: 436-444.
13. Graves EE, Nelson SJ, Vigneron DB, Verhey L, McDermott M, Larson D, Chang S, Prados MD, Dillon WP. Serial Proton MR Spectroscopic Imaging of Recurrent Malignant Gliomas after Gamma Knife Radiosurgery. AJNR Am J Neuroradiol 2001; 22: 613-624.
14. Grossman SA, Batara JF. Current management of glioblastoma multiforme. Semin Oncol 2004; 31: 635-644.
15. Haymaker W, Ibrahim MZ, Miquel J, Call N. Riopelle AJ. Delayed radiation effects in the brains of monkeys exposed to X- and g-rays. J Neuropathol Exp Neurol 1968; 27: 50-7.
16. Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 2009; 30: 552-558.
17. Hein PA, Eskey CJ, Dunn JF, Hug EB. Diffusion-Weighted Imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004; 25: 201-209.
18. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA. Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment. Radiology 2000; 217: 377-384.
19. Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G. Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility- weighted Contrast-enhanced Perfusion MR Imaging. Radiology 2008; 247: 490-498.
20. Lichy MP, Henze M, Plathow C, Bachert P, Kauczor HU, Schlemmer HP. Metabolic imaging to follow stereotactic radiation of gliomas - the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT. Rofo 2004; 176: 1114-1121. (Pubitemid 39118852)
21. Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A, Baram J, Orenstein A, Cohen JS, Tichler T. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high bvalue diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003; 21: 1094-1100.
22. Marcial-Vega VA, Wharam MD, Leibel S, Clark A, Zweig R, Order SE. Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1989; 16: 1419-1424. (Pubitemid 19154324)
23. Matulewicz Ł, Sokol M, Wydmanski J, Hawrylewicz L. Could lipid CH2/CH3 analysis by in vivo 1H MRS help in differentiation of tumor recurrence and post-radiation effects? Folia Neuropathol 2006; 44: 116-124.
24. Mishima N, Tamiya T, Matsumoto K, Furuta T, Ohmoto T. Radiation damage to the normal monkey brain: Experimental study induced by interstitial irradiation. Acta Med Okayama 2003; 57: 123-131. (Pubitemid 37386882)
25. Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis AJNR Am J Neuroradiol 2005; 26: 1967-1972.
26. Nieder C, Andratschke N, Price RE, Rivera B, Ang KK. Innovative prevention strategies for radiation necrosis of the central nervous system. Anticancer Res 2002; 22(2A): 1017-1023. (Pubitemid 34475266)
27. Pöpperl G, Götz C, Rachinger W, Gildehaus FJ, Tonn JC, Tatsch K. Value of O-(2-[18F] fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 2004; 31: 1464-1470. (Pubitemid 39592765)
28. Provenzale JM. Imaging of angiogenesis: clinical techniques and novel imaging methods. AJR Am J Roentgenol 2007; 188: 11-23. (Pubitemid 46012485)
29. Provenzale JM, Mukundan S, Barboriak DP. Diffusion weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006; 239: 632-649. (Pubitemid 43830599)
30. Rabinov JD, Lee PL., Barker FG. In vivo 3T MR spectroscopy in the distinction of recurrent glioma versus Radiation effects: initial experience. Radiology 2000; 225: 871-879.
31. Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, Mikkelsen T. Associations among magnetic resonance spectroscopy , apparent diffusion coefficients and image guided histopathology with special attention to radiation necrosis. Neurosurgery 2004; 54: 1111-1117.
32. Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T. Correlations between magnetic resonance spectroscopy and imageguided histopathology, with special attention to radiation necrosis. Neurosurgery 2002; 51: 912-919; discussion 919-920.
33. Rowley HA, Grant P, Roberts T. Diffusion MR imaging. Theory and applications. Neuroimaging Clin N Am 1999; 9: 343-361.
34. Rosen BR, Belliveau JW, Vevea JM. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14: 249-265.
35. Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 499-508.
36. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001; 22: 1316-1324.
37. Shaw EG, Daumas-Duport C, Scheithauer BW, Gilbertson DT, O'Fallon JR, Earle JD, Laws ER Jr, Okazaki H. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989; 70: 853-861. (Pubitemid 19150501)
38. Shields AF. PET imaging with 18F-FLT and thymidine analogs:promise and pitfalls. J Nucl Med 2003; 44: 1432-1434.
39. Stupp R, Roila F; ESMO Guidelines Working Group. Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 Suppl 2: ii83-85.
40. Sundgren PC, Fan X, Weybright P, Welsh RC, Carlos RC, Petrou M, McKeever PE, Chenevert TL. Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging 2006; 24: 1131-1142. (Pubitemid 44635065)
41. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M. Correlation of MR imaging-determined Cerebral Blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 1998; 171: 1479-1485.
42. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M. Posttherapeutic Intraaxial Brain Tumor: The value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue AJNR Am J Neuroradiol 2000; 21: 901-909.
43. Tashima T, Morioka T, Nishio S, Hachisuga S, Fukui M, Sasaki M. Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography. Neuroradiology 1998; 40: 435-438. (Pubitemid 28347280)
44. Taylor JS, Langston JW, Reddick WE, Kingsley PB, Ogg RJ, Pui MH, Kun LE, Jenkins JJ 3rd, Chen G, Ochs JJ, Sanford RA, Heideman RL. Clinical Value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 1996; 36: 1251-1261.
45. Träber F, Block W, Flacke S, Lamerichs R, Schüller H, Urbach H, Keller E, Schild HH. 1H-MR Spectroscopy of brain tumors in the course of radiation therapy: use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence. Rofo 2002; 174: 33-42.
46. Weisskoff RM, Belliveau J, Kwong K. Functional MR imaging of capillary hemodynamics. In: Potchen EJ, Jaacke EM, Siebert JE. Magnetic Resonance Angiography: Concepts and Applications. CV Mosby, St. Louis 1992; pp. 473-484.
47. Weybright P, Sundgren PC, Maly P, Hassan DG, Nan B, Rohrer S, Junck L. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 2005; 185: 1471-1476.
48. Van Tassel P, Bruner JM, Maor MH, Leeds NE, Gleason MJ, Yung WK, Levin VA. MR of Toxic Effects of Accelerated Fractionation Radiation Therapy and Carboplatin Chemotherapy for Malignant Gliomas. AJNR Am J Neuroradiol 1995; 16: 715-726.
49. Zeng QS, Li CF, Liu H, Zhen JH, Feng DC. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion- weighted imaging. Int J Radiation Oncology Biol Phys 2007; 68: 151-158. (Pubitemid 46589825)